• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE AUTOGUARD; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE AUTOGUARD; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number NS381834
Device Problem Retraction Problem (1536)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/18/2024
Event Type  malfunction  
Event Description
It was reported that bd insyte autoguard needle did not retract.The following information was provided by the initial reporter: needle without retraction after use.
 
Manufacturer Narrative
H.3.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.
 
Manufacturer Narrative
Investigation results: the complaint of retraction issues was confirmed from the two samples that were provided for investigation.The needle on the 1st sample failed to retract due to misplaced adhesive, which bonded the needle hub to the grip.This sample was confirmed for 'needle retraction failure'.During manufacturing, adhesive is dispensed into the hub to secure the cannula.Station misalignment may cause the adhesive to pour on the outside of the hub which can then flow in between the needle hub and the grip or the button.This may cause partial/slow/ or no retraction.A vision system software is in place to mitigate the occurrence of this defect.The needle on the 2nd sample was partially retracted, but the needle hub was caught on a damaged edge inside the shield at the interface of the barrel and grip.Since the safety mechanism was activated and the needle was partially retracted, the 2nd sample was confirmed for 'needle shielding failure'.During manufacturing, the barrel is seated to proper position.Improper machine set-up or misalignment may cause a damaged shield (grip/barrel) which may result in partial or no retraction.Machine 100% inspection and a quality control plan audit is performed to mitigate the occurrence of this defect.Both issues were manufacturing related and the appropriate manufacturing personnel were notified of this complaint.A trend was identified for needle retraction failure complaints.A capa and sa were opened to address this issue.This complaint type and corrective action will continue to be monitored for effectiveness.A notification of awareness has been sent to the manufacturing department.Complaints received for this device and reported condition will continue to be tracked and trended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE AUTOGUARD
Type of Device
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key18918939
MDR Text Key337856342
Report Number1710034-2024-00192
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
UNK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue NumberNS381834
Device Lot Number3114871
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/25/2024
Initial Date FDA Received03/16/2024
Supplement Dates Manufacturer Received04/18/2024
Supplement Dates FDA Received04/29/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/26/2023
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-